Clinical trial
Prospective Multicenter Post-market Study of the Zimmer NexGen LPS-Flex Porous Femoral Components
NCT01462240 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multicenter Post-market Study of the Zimmer NexGen LPS-Flex Porous Femoral Components
- Lead sponsor
- Zimmer Biomet
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- May 20, 2008
- Completion date
- March 31, 2012
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
avascular necrosis of femoral condyle, collagen disorders, osteoarthritis, poly arthritis, rheumatoid arthritis, traumatic arthritis